TAF
UTHR icon

Tredje AP-fonden’s United Therapeutics UTHR Stock Holding History

Tredje AP-fonden’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.65M Sell
6,732
-6,395
-49% -$3.6M 0.02% 396
2026
Q1 		$7.78M Buy
13,127
+7,566
+136% +$3.77M 0.04% 376
2025
Q4 		$2.71M Buy
5,561
+1,241
+29% +$578K 0.02% 245
2025
Q3 		$1.81M Sell
4,320
-866
-17% -$291K 0.01% 288
2025
Q2 		$1.49M Buy
5,186
+506
+11% +$151K 0.01% 290
2025
Q1 		$1.44M Hold
4,680
– – 0.01% 281
2024
Q4 		$1.65M Sell
4,680
-4,679
-50% -$1.72M 0.01% 305
2024
Q3 		$3.35M Hold
9,359
– – 0.03% 265
2024
Q2 		$2.98M Sell
9,359
-142
-1% -$37.6K 0.03% 269
2024
Q1 		$2.18M Buy
9,501
+2,071
+28% +$467K 0.02% 346
2023
Q4 		$1.63M Sell
7,430
-332
-4% -$76.5K 0.02% 418
2023
Q3 		$1.75M Sell
7,762
-595
-7% -$137K 0.03% 395
2023
Q2 		$1.84M Sell
8,357
-1,307
-14% -$290K 0.03% 402
2023
Q1 		$2.16M Buy
+9,664
New +$2.38M 0.03% 375
2017
Q4 		– Sell
-4,060
Closed -$476K – 584
2017
Q3 		$476K Sell
4,060
-8,040
-66% -$1.03M 0.02% 504
2017
Q2 		$1.57M Buy
12,100
+4,350
+56% +$543K 0.06% 357
2017
Q1 		$1.05M Sell
7,750
-2,675
-26% -$405K 0.04% 425
2016
Q4 		$1.5M Sell
10,425
-275
-3% -$35.1K 0.06% 336
2016
Q3 		$1.26M Buy
10,700
+4,420
+70% +$531K 0.06% 338
2016
Q2 		$665K Buy
6,280
+5,870
+1,432% +$655K 0.03% 383
2016
Q1 		$44K Buy
+410
New +$51.9K ﹤0.01% 438

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Tredje AP-fonden's UTHR Position: Q2 2026 in Review

Tredje AP-fonden reduced its United Therapeutics (UTHR) stake by 49% in Q2 2026, selling an estimated $3.6M and leaving 6,732 shares worth $3.65M. The position accounts for 0.02% of the portfolio, ranked #396.

Tredje AP-fonden first reported a position in UTHR in Q1 2016 and has held it in 21 quarters since. The position peaked at $7.78M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Tredje AP-fonden held 6,732 shares of United Therapeutics worth $3.65M as of Q2 2026.
  • Tredje AP-fonden sold 6,395 United Therapeutics shares in Q2 2026, an estimated $3.6M.
  • United Therapeutics made up 0.02% of Tredje AP-fonden's portfolio in Q2 2026, its #396 holding.
  • Tredje AP-fonden first reported a position in United Therapeutics in Q1 2016 and has held it in 21 quarters since.
  • Tredje AP-fonden's United Therapeutics position peaked at $7.78M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.